GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inventionmed SA (WAR:INM) » Definitions » EV-to-FCF

Inventionmed (WAR:INM) EV-to-FCF : -9.89 (As of Dec. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Inventionmed EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Inventionmed's Enterprise Value is zł37.92 Mil. Inventionmed's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was zł-3.84 Mil. Therefore, Inventionmed's EV-to-FCF for today is -9.89.

The historical rank and industry rank for Inventionmed's EV-to-FCF or its related term are showing as below:

WAR:INM' s EV-to-FCF Range Over the Past 10 Years
Min: -267.36   Med: 139.09   Max: 724.53
Current: -10.36

During the past 11 years, the highest EV-to-FCF of Inventionmed was 724.53. The lowest was -267.36. And the median was 139.09.

WAR:INM's EV-to-FCF is ranked worse than
100% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.76 vs WAR:INM: -10.36

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Inventionmed's stock price is zł0.171. Inventionmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was zł-0.025. Therefore, Inventionmed's PE Ratio (TTM) for today is At Loss.


Inventionmed EV-to-FCF Historical Data

The historical data trend for Inventionmed's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventionmed EV-to-FCF Chart

Inventionmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.78 -8.02 9.29 -4.11 -3.71

Inventionmed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.83 -3.71 -3.96 -6.83 -9.78

Competitive Comparison of Inventionmed's EV-to-FCF

For the Medical Devices subindustry, Inventionmed's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventionmed's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inventionmed's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Inventionmed's EV-to-FCF falls into.



Inventionmed EV-to-FCF Calculation

Inventionmed's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=37.922/-3.835
=-9.89

Inventionmed's current Enterprise Value is zł37.92 Mil.
Inventionmed's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-3.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventionmed  (WAR:INM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Inventionmed's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.171/-0.025
=At Loss

Inventionmed's share price for today is zł0.171.
Inventionmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.025.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Inventionmed EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Inventionmed's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventionmed Business Description

Traded in Other Exchanges
N/A
Address
ul. Bydgoskich, Przemyslowcow 6, Bydgoszcz, POL, 85-862
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The firm's flagship project consists of TutorDerm, a simulator and an application that allow performing the activities necessary to treat specific dermatological conditions.

Inventionmed Headlines

From GuruFocus

InMed Submits Form 12b-25

By GlobeNewswire GlobeNewswire 02-10-2023

InMed Submits Form 12b-25

By sperokesalga sperokesalga 02-10-2023

Q2 2020 InMed Pharmaceuticals Inc Earnings Call Transcript

By GuruFocus Research 03-06-2024

InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria

By GlobeNewswire GlobeNewswire 08-23-2022

InMed Announces Results of 2022 Annual General Meeting

By Value_Insider Value_Insider 12-16-2022

InMed Announces Changes to its Board of Directors

By PurpleRose PurpleRose 08-09-2022

Q3 2021 InMed Pharmaceuticals Inc Earnings Call Transcript

By GuruFocus Research 03-06-2024